This inventor holds 1 USPTO granted patent. Top assignee: Inipharm, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Rajendra Kristam: Innovator in Liver Disease Treatment
Introduction
Rajendra Kristam is a notable inventor based in Karnataka, India. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of liver diseases. His innovative work focuses on developing compounds that can effectively address serious health conditions.
Latest Patents
Rajendra Kristam holds a patent for HSD17B13 inhibitors and their uses. This patent describes pharmaceutical compositions that include these inhibitors, which are useful for treating liver disease, metabolic disease, or cardiovascular disease. Conditions such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and drug-induced liver injury (DILI) are specifically targeted by his inventions. He has 1 patent to his name.
Career Highlights
Rajendra Kristam is currently associated with Inipharm, Inc., where he continues to advance his research and development efforts. His work is pivotal in creating effective treatments that can improve patient outcomes in liver-related health issues.
Collaborations
Some of his notable coworkers include Joshua Odingo and Heather Kay Webb Hsu. Their collaborative efforts contribute to the innovative environment at Inipharm, Inc.
Conclusion
Rajendra Kristam's contributions to the field of pharmaceuticals, particularly through his patent on HSD17B13 inhibitors, highlight his commitment to addressing critical health challenges. His work exemplifies the impact of innovation in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile